InnoCan Pharma Corporation
INNO
株式のランク
#33926
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to... InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems that integrate cannabidiol (CBD) with other pharmaceutical compounds. Its operations and development efforts span across the United States, Poland, France, and various international markets. The company actively pursues research and development into treatments for conditions such as COVID-19, leveraging CBD delivered via exosomes and liposomes. InnoCan's product line features a range of CBD-infused topical items, including eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Beyond R&D, the corporation is also involved in the marketing and distribution of its proprietary CBD-enhanced pharmaceutical and cosmetic offerings. Established in 2018, InnoCan Pharma Corporation maintains its principal office in Calgary, Canada.
株価
$1.39
最終同期: 2026-10-15
時価総額
$6.27M
変化（1日）
0.00%
変化（1年）
-88.85%
国
CA
取引 InnoCan Pharma Corporation (INNO)
カテゴリー
Healthcare
の時価総額 InnoCan Pharma Corporation(INNO)
時価総額: $6.27M
October 2026時点で、InnoCan Pharma Corporation の時価総額は $6.27M です。これは、当社のデータによると、InnoCan Pharma Corporation が世界で33926th番目に価値のある企業であることを意味します。時価総額は、上場企業の発行済株式の総市場価値であり、企業の価値を測るためによく使用されます。
InnoCan Pharma Corporation の時価総額の履歴（2020 から 2026 まで）
